Effect of mitral regurgitation on left ventricular thrombus formation in dilated cardiomyopathy
DOI 10.1016/S0002-8703(98)70084-5
Kalaria VG, Passannante MR, Shah T, Modi K, Weisse AB. Effect of mitral regurgitation on left ventricular thrombus formation in dilated cardiomyopathy. Am Heart J 1998;135:215-20. (Pubitemid 28139159)
Acute coronary findings at autopsy in heart failure patients with sudden death: Results from the assessment of treatment with lisinopril and survival (ATLAS) trial
Uretsky BF, Thygesen K, Armstrong PW, et al. Acute coronary findings at autopsy in heart failure patients with sudden death: results from the Assessment of Treatment With Lisinopril and Survival (ATLAS) trial. Circulation 2000;102:611-6. (Pubitemid 30640659)
Should we use anticoagulation for patients with chronic heart failure?
DOI 10.1038/ncpcardio0688, PII NCPCARDIO0688
Freudenberger RS, Halperin JL. Should we use anticoagulation for patients with chronic heart failure? Nat Clin Pract Cardiovasc Med 2006;3:580-1. (Pubitemid 44614915)
Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: A statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke - Co-sponsored by the Council on Cardiovascular Radiology and Intervention. The American Academy of Neurology affirms the value of this guideline
DOI 10.1161/01.STR.0000199147.30016.74, PII 0000301720060314000024
Sacco RL, Adams R, Albers G, et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Circulation 2006;113(10):e409-e449. (Pubitemid 43739468)
The effects of dicumarol upon the mortality and incidence of thromboembolic complications in congestive heart failure
Anderson GM, Hull E. The effects of dicumarol upon the mortality and incidence of thromboembolic complications in congestive heart failure. Am Heart J 1950;39:697-702.
A study of the beneficial effects of anticoagulant therapy in congestive heart failure
Griffith GC, Stragnell R, Levinson DC, Moore FJ, Ware AG. A study of the beneficial effects of anticoagulant therapy in congestive heart failure. Ann Intern Med 1952;37:867-87.
Warfarin anticoagulation and survival: A cohort analysis from the Studies of Left Ventricular Dysfunction
DOI 10.1016/S0735-1097(98)00006-0, PII S0735109798000060
Al-Khadra AS, Salem DN, Rand WM, Udelson JE, Smith JJ, Konstam MA. Warfarin anticoagulation and survival: a cohort analysis from the Studies of Left Ventricular Dysfunction. J Am Coll Cardiol 1998;31:749-53. (Pubitemid 28186406)
Ventricular dysfunction and the risk of stroke after myocardial infarction
DOI 10.1056/NEJM199701233360403
Loh E, Sutton MS, Wun CC, et al. Ventricular dysfunction and the risk of stroke after myocardial infarction. N Engl J Med 1997;336:251-7. (Pubitemid 27044626)
Risk of thromboembolism in heart failure: An analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)
DOI 10.1161/CIRCULATIONAHA.106.661397
Freudenberger RS, Hellkamp AS, Halperin JL, et al. Risk of thromboembolism in heart failure: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Circulation 2007;115:2637-41. (Pubitemid 46791362)
(2007)Circulation, vol.115, Issue.20, pp. 2637-2641
The Warfarin/Aspirin study in heart failure (WASH): A randomized trial comparing antithrombotic strategies for patients with heart failure
DOI 10.1016/j.ahj.2004.03.010, PII S000287030400136X
Cleland JGF, Findlay I, Jafri S, et al. The Warfarin/Aspirin Study in Heart Failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure. Am Heart J 2004; 148:157-64. (Pubitemid 38900496)
Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: The Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) trial
Massie BM, Collins JF, Ammon SE, et al. Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) trial. Circulation 2009;119: 1616-24.
Test of an algorithm for simulating prothrombin times in a double-blind anticoagulation drug trial
abstract
Thompson JLP, Fleiss JL, James K, et al. Test of an algorithm for simulating prothrombin times in a double-blind anticoagulation drug trial. Ann Neurol 1994; 36:305-6. abstract.
A method to determine the optimal intensity of oral anticoagulant therapy
Rosendaal FR, Cannegieter SC, van der Meer FJ, Briët E. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost 1993;69: 236-9. (Pubitemid 23069000)
A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke
Mohr JP, Thompson JL, Lazar RM, et al. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med 2001;345:1444-51.
Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: A meta-analysis
Hart RG, Benavente O, McBride R, Pearce LA. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med 1999;131:492-501. (Pubitemid 29482392)
Counteraction of the vasodilator effects of enalapril by aspirin in severe heart failure
Hall D, Zeitler H, Rudolph W. Counteraction of the vasodilator effects of enalapril by aspirin in severe heart failure. J Am Coll Cardiol 1992;20:1549-55. (Pubitemid 23007509)
Acute hemodynamic interaction of aspirin and ticlopidine with enalapril: Results of a double-blind, randomized comparative trial
Spaulding C, Charnonnier B, Cohen- Solal A, et al. Acute hemodynamic interaction of aspirin and ticlopidine with enalapril: results of a double-blind, randomized comparative trial. Circulation 1998;98:757-65. (Pubitemid 28391840)
Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): A randomised controlled trial
DOI 10.1016/S0140-6736(02)09409-6
van Es RF, Jonker JJ, Verheugt FW, Deckers JW, Grobbee DE. Aspirin and Coumadin After Acute Coronary Syndromes (the ASPECT-2 study): a randomized controlled trial. Lancet 2002;360:109-13. (Pubitemid 34786198)
Dabigatran versus warfarin in patients with atrial fibrillation
Erratum, N Engl J Med 2010;363:1877
Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009;361:1139-51. [Erratum, N Engl J Med 2010;363:1877.]